Correction/clarification about FDA review documents.

Correction/clarification about FDA review documents.

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2005-12-01
Series:	PLoS Medicine
Online Access:	http://dx.doi.org/10.1371/journal.pmed.0020422

Similar Items

Correction/clarification about FDA review documents.
by: Erick Turner
Published: (2005-12-01)

Patient-reported outcomes in breast cancer FDA drug labels and review documents
by: Kyungwan Hong, et al.
Published: (2021-04-01)

FORUM: Review clarification
by: Geraldene Peters
Published: (2004-04-01)

Clarification
by: Henk van Riemsdijk
Published: (2008-03-01)

FDA Expands Warning to Consumers About Tained Weight Loss Pills.
Published: (2009-03-01)

Publication of clarifications
by: article Editorial
Published: (2019-02-01)

Characteristics of pivotal trials and FDA review of innovative devices.
by: Joshua P Rising, et al.
Published: (2015-01-01)

Factors influencing the time for FDA review of medical devices
by: Singh, Inder Raj, S.M. Massachusetts Institute of Technology
Published: (2008)

Clarifications, guidelines and questions about the dental bleaching "associated" with orthodontic treatment
by: Alberto Consolaro, et al.
Published: (2013-10-01)

A clarification on the Dispute about Menicus theory of human nature in modern age.
by: Tzu-Ling Chen, et al.
Published: (2012)

2018 FDA Tides Harvest
by: Danah Al Shaer, et al.
Published: (2019-04-01)

2017 FDA Peptide Harvest
by: Othman Al Musaimi, et al.
Published: (2018-05-01)

FDA commissioner Gottlieb resigns
by: Robbins RA
Published: (2019-03-01)

Clarification of guava juice
by: CHEN,HUI-RONG, et al.
Published: (1990)

Magnetophoretic cell clarification
by: Sharpe, Sonja Ann, 1974-
Published: (2005)

Some Clarifications about the Argumentative Theory of Reasoning. A Reply to Santibáñez Yañez (2012).
by: Hugo Mercier
Published: (2012-06-01)

New Clarification About Observation Billing May Improve Care for Behavioral Health Patients
by: Anwar D. Osborne, et al.
Published: (2020-01-01)

Some Clarifications about the Argumentative Theory of Reasoning. A Reply to Santibáñez Yañez (2012).
by: Hugo Mercier
Published: (2012-06-01)

Book review - Identity and personhood: Confusions and clarifications across disciplines
by: Laura D’Olimpio
Published: (2015-11-01)

Why did the FDA approve these advertisements?
by: David Oaks
Published: (2006-02-01)

Drugs, Devices, and the FDA: Part 2
by: Gail A. Van Norman, MD
Published: (2016-06-01)

Drugs, Devices, and the FDA: Part 1
by: Gail A. Van Norman, MD
Published: (2016-04-01)

Insights from FDA Warning Letters
Published: (2010-01-01)

Gottlieb, the FDA and dumbing down medicine
by: Robbins RA
Published: (2017-04-01)

FDA Public Advisory for Nevirapine (Viramune)
by: Editorial Office
Published: (2005-05-01)

Assessing biodiversity profile through FDA
by: Tonio Di Battista, et al.
Published: (2013-10-01)

FDA approved ready to use phenylephrine
by: Pradeep Kumar Bhatia, et al.
Published: (2021-01-01)

Announcement Effect of Drug Approvals by FDA
by: Ting, Hsiu Wen, et al.
Published: (2008)

An FDA Implementation of Multi-prototype Classification
by: Jian-Li Kuo, et al.
Published: (2010)

Tree Centroid Properties Clarification
by: Yurii A. Belov, et al.
Published: (2017-08-01)

Clarification on Islamic Jurisprudence and Transplantation
by: Andrew C. Miller, MD, et al.
Published: (2020-08-01)

VetCompanion: response and clarifications
by: Matthew Paul Mauer, et al.
Published: (2017-07-01)

Behavioral clarification of rating dimensions /
by: Schaalman, Mary Lou Finnegan
Published: (1984)

Clarification of Ageism in the Care System
by: Saeid Mehri, et al.
Published: (2020-03-01)

Floc blanket clarification of water
by: Hale, Peter Everest
Published: (1971)

Clarification of Ellen Glasgow's perspectives
by: Guilmartin, Alice Josephine
Published: (2016)

Clarification about editorial endogamy in the Revista Peruana de Medicina Experimental y Salud Publica
by: J. Jhonnel Alarco, et al.
Published: (2019-12-01)

Review of FDA Public Hearing Transcript on Behind-the-Counter Availability of Certain Drugs
by: Reiss, Matthew, et al.
Published: (2009)

Review of FDA Public Hearing Transcript on Behind-the-Counter Availability of Certain Drugs
by: Rasmussen, Ashli, et al.
Published: (2010)

Chemical Crosslinking of 6FDA-ODA and 6FDA-ODA:DABA for Improved CO2/CH4 Separation
by: Mohd Zamidi Ahmad, et al.
Published: (2018-08-01)